<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05116397</url>
  </required_header>
  <id_info>
    <org_study_id>USARIEM</org_study_id>
    <nct_id>NCT05116397</nct_id>
  </id_info>
  <brief_title>Influence of Graded Hypercapnia on Endurance Exercise Performance</brief_title>
  <official_title>Influence of Graded Hypercapnia on Endurance Exercise Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Army Research Institute of Environmental Medicine</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Army Research Institute of Environmental Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized, single-blind, placebo-controlled crossover trial is to determine&#xD;
      the effects of graded hypercapnia (0, 2, and 4% inspired CO2) on endurance performance.&#xD;
      Twelve healthy and fit young adults (men and women) will complete this study. Participants&#xD;
      will perform experimental trials on 3 separate days (one each breathing 0%, 2%, and 4%&#xD;
      inspired CO2-all with normal 21% oxygen). During each trial, they will perform 10 minutes of&#xD;
      submaximal treadmill walking exercise and then complete a self-paced 2-mile treadmill run&#xD;
      time-trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will undergo baseline measurements of pulmonary function and maximal oxygen&#xD;
      uptake (VO2max). They will then complete two familiarization trials, with 10 minutes of&#xD;
      submaximal exercise (~40%VO2max) followed by a self-paced 2-mile treadmill time trial.&#xD;
      Lastly, they will complete three experimental trials, repeating the same submaximal and&#xD;
      time-trial exercise procedures while breathing the test gas (0%, 2%, or 4% CO2-all with&#xD;
      normal 21% oxygen). During the experimental trials, arterialized capillary blood samples will&#xD;
      be collected at rest breathing room air, at rest breathing the test gas, and during&#xD;
      submaximal exercise at 40% VO2max breathing the test gas. The primary outcome is 2-mile&#xD;
      treadmill time-trial performance. Secondary outcomes include ventilation, metabolic rate,&#xD;
      heart rate, arterialized capillary pH/PCO2/HCO3, perceived exertion, dyspnea, leg discomfort,&#xD;
      breathing descriptors, and headache ratings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2021</start_date>
  <completion_date type="Anticipated">September 9, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 9, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized, single-blinded crossover design</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single-blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>2 mile self-paced treadmill time trial performance</measure>
    <time_frame>30 minutes</time_frame>
    <description>Time to complete self-paced 2 mile treadmill time trial (min:sec)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilation rate</measure>
    <time_frame>30 minutes</time_frame>
    <description>Ventilation rate will be assessed using a pneumotachometer [L/min]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen consumption</measure>
    <time_frame>30 minutes</time_frame>
    <description>Oxygen consumption will be assessed using computerized indirect calorimetry [ml/kg/min]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>30 minutes</time_frame>
    <description>Heart rate will be assessed using telemetry [beats per min]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterialized capillary pH</measure>
    <time_frame>30 minutes</time_frame>
    <description>Arterialized capillary pH will be assessed using a blood gas analyzer [Unitless]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterialized capillary pCO2</measure>
    <time_frame>30 minutes</time_frame>
    <description>Arterialized capillary pCO2 will be assessed using a blood gas analyzer [mmHg]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterialized capillary HCO3</measure>
    <time_frame>30 minutes</time_frame>
    <description>Arterialized capillary HCO3 will be assessed using a blood gas analyzer [mEq/L]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rating of perceived exertion</measure>
    <time_frame>30 minutes</time_frame>
    <description>Rating of perceived exertion will be assessed using Borg's 6-20 scale [AU]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>30 minutes</time_frame>
    <description>Rating of perceived dyspnea will be assessed using Borg's 0-10 scale [AU]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leg discomfort</measure>
    <time_frame>30 minutes</time_frame>
    <description>Rating of perceived leg discomfort will be assessed using Borg's 0-10 scale [AU]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache</measure>
    <time_frame>30 minutes</time_frame>
    <description>Headache will be assessed using a visual analog scale [AU]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breathing descriptors</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing descriptors will be assessed by having participants check statements that apply to their breathing (e.g., breathing out requires more effort) [unitless]</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Hypercapnia</condition>
  <arm_group>
    <arm_group_label>4% CO2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inspired gas containing 4% CO2, 21% O2, balance N2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2% CO2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inspired gas containing 2% CO2, 21% O2, balance N2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0% CO2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Inspired gas containing 0% CO2, 21% O2, balance N2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inspired gas</intervention_name>
    <description>Inspired gas content</description>
    <arm_group_label>0% CO2</arm_group_label>
    <arm_group_label>2% CO2</arm_group_label>
    <arm_group_label>4% CO2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female, age 18-45&#xD;
&#xD;
          -  In good health as determined by medical screening&#xD;
&#xD;
          -  Passed his/her most recent Army Combat Fitness Test (ACFT) (Military Volunteers Only)&#xD;
             or performs aerobic exercise at least 2 times per week and able to complete two mile&#xD;
             run in â‰¤ 21 minutes (Civilian Volunteers)&#xD;
&#xD;
          -  Willing to not participate in any exercise or drink alcoholic beverages for 24 hours&#xD;
             before each study visit.&#xD;
&#xD;
          -  Willing to not take part in any strenuous exercise in the 36 hours before each visit.&#xD;
&#xD;
          -  Willing not to drink caffeine or eat food until after testing on familiarization and&#xD;
             performance testing visits (visits 2-6).&#xD;
&#xD;
          -  Willing to maintain a similar dietary pattern in the 2 days before each&#xD;
             familiarization and performance visits.&#xD;
&#xD;
          -  Have supervisor approval if permanent party military or a federal employee at U.S.&#xD;
             Army Natick Soldier System Center&#xD;
&#xD;
          -  Able to speak and read English fluently&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Females who are pregnant or planning to become pregnant during the study&#xD;
&#xD;
          -  Taking dietary supplements, prescriptions, or over the counter medication, other than&#xD;
             a contraceptive (unless approved by medical staff &amp; PI)&#xD;
&#xD;
          -  Musculoskeletal injuries that compromise ability to run on a treadmill&#xD;
&#xD;
          -  Abnormal blood count, presence of abnormal blood chemicals (hemoglobin S or sickle&#xD;
             cell traits)&#xD;
&#xD;
          -  Smokers or tobacco/nicotine users (unless have quit &gt; 1 month prior)&#xD;
&#xD;
          -  Any history of asthma&#xD;
&#xD;
          -  Current or recent respiratory tract or sinus infections (&lt; 1 month prior)&#xD;
&#xD;
          -  Allergy to skin adhesive&#xD;
&#xD;
          -  Any history of migraine or recurrent headaches&#xD;
&#xD;
          -  Any history of panic disorder&#xD;
&#xD;
          -  Blood donation in the previous 8 weeks&#xD;
&#xD;
          -  Positive Covid-19 test within the last month&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin J Ryan, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>United States Army Research Institute of Environmental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin J Ryan, Ph.D.</last_name>
    <phone>508-206-2408</phone>
    <email>benjamin.j.ryan14.civ@mail.mil</email>
  </overall_contact>
  <location>
    <facility>
      <name>USARIEM</name>
      <address>
        <city>Natick</city>
        <state>Massachusetts</state>
        <zip>01760</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin J Ryan, Ph.D.</last_name>
      <phone>508-206-2408</phone>
      <email>benjamin.j.ryan14.civ@mail.mil</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>October 30, 2021</last_update_submitted>
  <last_update_submitted_qc>October 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

